Date Filed | Type | Description |
08/14/2023 |
SC 13G/A
| RA CAPITAL MANAGEMENT, L.P. reports a 0% stake in Bellus Health Inc. |
07/10/2023 |
15-12G
| Form 15-12G - Securities registration termination [Section 12(g)]: |
06/28/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/28/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/28/2023 |
S-8 POS
| Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendments: |
06/28/2023 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities: |
06/16/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
06/06/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
Docs:
|
"FORM 6-K",
"BELLUS HEALTH INC. NOTICE OF ANNUAL AND SPECIAL MEETING OF SHAREHOLDERS NOTICE is hereby given that the annual and special meeting of the common shareholders of BELLUS Health Inc. will be held in person at 275 Armand Frappier Blvd., Laval, Québec, H7V 4A7 on June 30, 2023 at 11:30 a.m., Montréal time, for the following purposes: to receive and consider the annual report of the directors to the shareholders and the financial statements of the Company for the financial year ended December 31, 2022, and the report of the auditors thereon; to elect each of the directors for the ensuing year; to appoint KPMG LLP, Chartered Accountants, as auditors of the Company and to authorize the Audit Committee to fix the auditors’ remuneration; to ratify and confirm the resolution approving t...",
"------- Fold ------- Fold Appointment of Proxyholder I/We being holder of securities of BELLUS Health Inc. hereby appoint: Dr. Francesco Bellini, O.C., or failing this person, Mr. Roberto Bellini, or failing this person, Mr. Ramzi Benamar, or failing this person, Mr. Sébastien Roy OR Print the name of the person you are appointing if this person is someone other than the Management Nominees listed herein. as my/our proxyholder with full power of substitution and to attend, act and to vote for and on behalf of the holder in accordance with the following direction and on all other matters that may properly come before the Annual and Special Meeting of shareholders of the Company to be held at 275 Armand Frappier Blvd., Laval, Québec, H7V 4A7 on June 30, 2023 at 11:30 am, and at any..." |
|
06/02/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
05/19/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
05/16/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
05/12/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
04/28/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
04/27/2023 |
6-K
| Quarterly results |
04/18/2023 |
6-K
| Quarterly results |
04/05/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
03/29/2023 |
6-K
| Quarterly results |
03/23/2023 |
40-F
| Form 40-F - Registration statement [Section 12] or Annual Report [Section 13(a), 15(d)]: |
03/21/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
03/21/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
03/01/2023 |
6-K
| Quarterly results |
02/24/2023 |
6-K
| Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]: |
02/14/2023 |
SC 13G/A
| COMMODORE CAPITAL LP reports a 4.2% stake in BELLUS Health Inc. |
02/14/2023 |
SC 13G/A
| PERCEPTIVE ADVISORS LLC reports a 7.1% stake in Bellus Health Inc. |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2023 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/13/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
02/08/2023 |
6-K
| Quarterly results |
02/03/2023 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals: |
01/23/2023 |
SC 13G/A
| Power Corp of Canada reports a 3.9% stake in Bellus Health Inc. |
11/14/2022 |
6-K
| Quarterly results |
11/14/2022 |
SUPPL
| Form SUPPL - Voluntary Supplemental Material by Foreign Issuers [Section 11(a)]: |
11/14/2022 |
6-K
| Quarterly results |
11/14/2022 |
6-K
| Quarterly results |
|